PNE Plus Exercise Versus Exercise for Chronic Rotator Cuff Tendinopathy

November 17, 2022 updated by: Ruben Fernandez Matias

Pain Neuroscience Education Plus Exercise Versus Exercise Alone in the Management of Chronic Rotator Cuff Tendinopathy: a Randomized Controlled Trial

The aim of this randomized controlled trial is to evaluate the combined effects of pain neuroscience education plus exercise to exercise alone in the management of patients with chronic rotator cuff tendinopathy regarding pain, function, strength, kinesiophobia, and pain catastrophizing.

Study Overview

Status

Suspended

Study Type

Interventional

Enrollment (Anticipated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Alcalá De Henares, Madrid, Spain, 28805
        • Rubén Fernández-Matías

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Shoulder pain due to rotator cuff tendinopathy lasting more than 6 months.
  • Internal Rotation Resisted Strength Test positive.
  • Test Item Cluster (Hawkins-Kennedy, painful arc, and infraspinatus test) positive.

Exclusion Criteria:

  • History of: tumors, metastasis, osteoporosis, shoulder fractures, shoulder luxation and/or instability, previous shoulder surgery, cervical radiculopathy, full-thickness rotator cuff tears, glenohumeral joint degeneration, inflammatory arthropathy, acromioclavicular joint arthrosis, and rotator cuff calcifications.
  • Being treated by other physical therapy or medical treatment for their shoulder pain at the time of recruitment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pain neuroscience education plus exercise
Three sessions of pain neuroscience education plus exercise.
Three sessions of pain neuroscience education based on explaining patients: characteristics of acute versus chronic pain, function of acute pain, how acute pain is originated within the nervous system, how acute pain progress to chronic pain, and factors that contribute to central sensitization (e.g., emotions, stress, disease and pain beliefs, behaviors regarding pain...). All the explanations will be conducted using easy-understandable examples and metaphors.
Progressive resistance exercise program based on isometric, concentric, eccentric, and pliometric contractions.
Active Comparator: Exercise alone
Exercise alone without pain neuroscience education.
Progressive resistance exercise program based on isometric, concentric, eccentric, and pliometric contractions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain intensity
Time Frame: Baseline, change from baseline at 4-week, and change from baseline at 12-week
Pain intensity measured with numerical pain rating scale which ranges from 0 points (no pain) to 10 points (worst imaginable pain)
Baseline, change from baseline at 4-week, and change from baseline at 12-week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder disability change
Time Frame: Baseline, change from baseline at 4-week, and change from baseline at 12-week
Shoulder disability measured with Shoulder Pain and Disability Index (SPADI). SPADI ranges from 0% (no disability) to 100% (maximum degree of disability).
Baseline, change from baseline at 4-week, and change from baseline at 12-week
Kinesiophobia change
Time Frame: Baseline, change from baseline at 4-week, and change from baseline at 12-week
Kinesiophobia measured with Tampa Scale for Kinesiophobia (TSK-11) which ranges from 0% (no kinesiophobia) to 100% (maximum degree of kinesiophobia).
Baseline, change from baseline at 4-week, and change from baseline at 12-week
Catastrophism change
Time Frame: Baseline, change from baseline at 4-week, and change from baseline at 12-week
Catastrophism measured with Pain Catastrophizing Scale (PCS) which ranges from 0% (no catastrophism) to 100% (maximum degree of catastrophism).
Baseline, change from baseline at 4-week, and change from baseline at 12-week
Strength change
Time Frame: Baseline, change from baseline at 4-week, and change from baseline at 12-week
Scaption strength at 90º of elevation measured with a hand-held dynamometer
Baseline, change from baseline at 4-week, and change from baseline at 12-week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 25, 2021

Primary Completion (Actual)

October 1, 2021

Study Completion (Anticipated)

October 1, 2029

Study Registration Dates

First Submitted

July 20, 2021

First Submitted That Met QC Criteria

July 28, 2021

First Posted (Actual)

August 2, 2021

Study Record Updates

Last Update Posted (Actual)

November 22, 2022

Last Update Submitted That Met QC Criteria

November 17, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tendinosis

Clinical Trials on Pain neuroscience education

3
Subscribe